Written answers

Tuesday, 9 November 2021

Department of Health

Medicinal Products

Photo of Michael FitzmauriceMichael Fitzmaurice (Roscommon-Galway, Independent)
Link to this: Individually | In context | Oireachtas source

622. To ask the Minister for Health further to Parliamentary Question No. 643 of 21 September 2021, if the HSE has sourced funding for the remaining four advanced nurse practitioners as part of the 2022 new service development process; and if he will make a statement on the matter. [54483/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

As this question relates to operational matters for the Health Service Executive (HSE), I have asked that the HSE responds to the Deputy directly.

Photo of Michael FitzmauriceMichael Fitzmaurice (Roscommon-Galway, Independent)
Link to this: Individually | In context | Oireachtas source

623. To ask the Minister for Health when he expects an inquiry will be established to investigate the historical licensing and prescribing of sodium valproate to pregnant women without them being made aware of the impacts it could have on their child; and if he will make a statement on the matter. [54484/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Details of the proposed inquiry into the historical licensing and use of sodium valproate among women of childbearing age in Ireland are currently being considered by officials within the Department of Health.

Comments

No comments

Log in or join to post a public comment.